• Thu, November 4, 2021

by: WOPRAI

Justin Kim Maintained (AUPH) at Hold with Increased Target to $33 on, Nov 4th, 2021

by: WOPRAI

David Turkaly Maintained (AXGN) at Buy with Decreased Target to $20 on, Nov 4th, 2021

by: WOPRAI

Insoo Kim Downgraded (AWK) to Hold and Decreased Target to $177 on, Nov 4th, 2021

by: WOPRAI

Matt Bryson Initiated (AXTI) at Buy and Held Target at $11 on, Nov 4th, 2021

by: WOPRAI

David George Maintained (WFC) at Buy and Held Target at $50 on, Nov 4th, 2021

by: WOPRAI

Andrew Charles Maintained (WING) at Buy with Decreased Target to $175 on, Nov 4th, 2021

by: WOPRAI

Christopher Carril Maintained (WING) at Hold with Decreased Target to $158 on, Nov 4th, 2021

by: WOPRAI

Sean Horgan Maintained (VIRT) at Strong Buy with Increased Target to $38 on, Nov 4th, 2021

by: WOPRAI

Rommel Dionisio Maintained (VSTO) at Strong Buy with Increased Target to $57 on, Nov 4th, 2021

by: WOPRAI

Steven Delaney Maintained (ACRE) at Buy and Held Target at $17 on, Nov 4th, 2021

by: WOPRAI

Neal Dingmann Upgraded (APA) to Strong Buy and Increased Target to $45 on, Nov 4th, 2021

by: WOPRAI

Pearce Hammond Downgraded (AMRC) to Hold and Increased Target to $96 on, Nov 4th, 2021

by: WOPRAI

John Heagerty Downgraded (AON) to Hold and Held Target at $320 on, Nov 4th, 2021

by: WOPRAI

Ben Bienvenu Upgraded (ANDE) to Buy and Increased Target to $48 on, Nov 4th, 2021

by: WOPRAI

Justin Patterson Maintained (ANGI) at Buy with Decreased Target to $16 on, Nov 4th, 2021

by: WOPRAI

Brent Thill Downgraded (ASAN) to Hold and Increased Target to $135 on, Nov 4th, 2021

by: WOPRAI

Michael Cyprys Maintained (APO) at Buy with Increased Target to $90 on, Nov 4th, 2021

by: WOPRAI

Gena Wang Maintained (BCRX) at Buy with Decreased Target to $17 on, Nov 4th, 2021

by: WOPRAI

Brian Abrahams Maintained (BCRX) at Hold with Decreased Target to $14 on, Nov 4th, 2021

by: WOPRAI

Michael King Maintained (AGIO) at Strong Buy with Increased Target to $95 on, Nov 4th, 2021

by: WOPRAI

Michael Phillips Maintained (AIZ) at Buy with Increased Target to $191 on, Nov 4th, 2021

by: WOPRAI

Mike Matson Maintained (ZBH) at Strong Buy with Decreased Target to $175 on, Nov 4th, 2021

by: WOPRAI

Andrew Berens Maintained (ZYME) at Hold with Decreased Target to $28 on, Nov 4th, 2021

by: WOPRAI

Jeffrey Stevenson Upgraded (BXC) to Strong Buy and Increased Target to $75 on, Nov 4th, 2021

by: WOPRAI

Brian Johnson Maintained (BWA) at Hold with Increased Target to $48 on, Nov 4th, 2021

by: WOPRAI

Joseph Spak Maintained (BWA) at Hold with Decreased Target to $47 on, Nov 4th, 2021

by: WOPRAI

Patrick O"Shaughnessy Maintained (BR) at Buy with Increased Target to $192 on, Nov 4th, 2021

by: WOPRAI

James Lee Maintained (BKNG) at Strong Buy on, Nov 4th, 2021

by: WOPRAI

Brad Erickson Maintained (BKNG) at Hold on, Nov 4th, 2021

by: WOPRAI

Andrew Boone Maintained (BKNG) at Buy on, Nov 4th, 2021

by: WOPRAI

Brian Nowak Maintained (BKNG) at Hold on, Nov 4th, 2021

by: WOPRAI

Maurice Choy Maintained (BIP) at Buy with Increased Target to $43 on, Nov 4th, 2021

by: WOPRAI

Kenneth Zener Maintained (BLD) at Buy with Increased Target to $300 on, Nov 4th, 2021

by: WOPRAI

Trey Grooms Maintained (BLD) at Hold with Increased Target to $285 on, Nov 4th, 2021

by: WOPRAI

Brian Vaccaro Maintained (CAKE) at Buy with Decreased Target to $53 on, Nov 4th, 2021

by: WOPRAI

Lauren Silberman Maintained (CAKE) at Hold with Decreased Target to $52 on, Nov 4th, 2021

by: WOPRAI

Brad Milsaps Upgraded (CADE) to Buy and Increased Target to $40 on, Nov 4th, 2021

by: WOPRAI

C. Gregory Peters Downgraded (ALL) to Buy and Decreased Target to $140 on, Nov 4th, 2021

by: WOPRAI

Michael Pachter Downgraded (AMC) to Sell and Held Target at $66 on, Nov 4th, 2021

by: WOPRAI

Whit Mayo Maintained (AMED) at Hold with Increased Target to $181 on, Nov 4th, 2021

by: WOPRAI

Frank Morgan Maintained (AMED) at Buy with Decreased Target to $221 on, Nov 4th, 2021

by: WOPRAI

Scott Fidel Maintained (AMED) at Hold with Increased Target to $185 on, Nov 4th, 2021

by: WOPRAI

Jonathan Yong Maintained (AMED) at Buy with Increased Target to $205 on, Nov 4th, 2021

by: WOPRAI

Danielle Antalffy Maintained (ATRC) at Buy with Increased Target to $110 on, Nov 4th, 2021

by: WOPRAI

Mike Matson Maintained (ATRC) at Strong Buy with Increased Target to $92 on, Nov 4th, 2021

by: WOPRAI

Joseph Schwartz Maintained (AUPH) at Buy with Increased Target to $35 on, Nov 4th, 2021

by: WOPRAI

Ed Arce Maintained (AUPH) at Strong Buy with Increased Target to $40 on, Nov 4th, 2021

by: WOPRAI

Robert Dodd Maintained (TSLX) at Buy with Increased Target to $25 on, Nov 4th, 2021

Jayson Bedford Maintained (TNDM) at Buy with Increased Target to $138 on, Nov 4th, 2021

Jayson Bedford of Raymond James, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Increased Target from $120 to $138 on, Nov 4th, 2021.

Jayson, nor any peers, have made any analyst calls on TNDM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍